BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3523704)

  • 1. Chemotherapeutic approach to control of onchocerciasis.
    Aziz MA
    Rev Infect Dis; 1986; 8(3):500-4. PubMed ID: 3523704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis.
    Awadzi K; Dadzie KY; Shulz-Key H; Haddock DR; Gilles HM; Aziz MA
    Ann Trop Med Parasitol; 1985 Feb; 79(1):63-78. PubMed ID: 3838638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.
    Greene BM; Taylor HR; Cupp EW; Murphy RP; White AT; Aziz MA; Schulz-Key H; D'Anna SA; Newland HS; Goldschmidt LP
    N Engl J Med; 1985 Jul; 313(3):133-8. PubMed ID: 3892293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement.
    Lariviere M; Vingtain P; Aziz M; Beauvais B; Weimann D; Derouin F; Ginoux J; Schulz-Key H; Gaxotte P; Basset D
    Lancet; 1985 Jul; 2(8448):174-7. PubMed ID: 2862370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of onchocerciasis. The ocular effects of ivermectin and diethylcarbamazine.
    Taylor HR; Murphy RP; Newland HS; White AT; D'Anna SA; Keyvan-Larijani E; Aziz MA; Cupp EW; Greene BM
    Arch Ophthalmol; 1986 Jun; 104(6):863-70. PubMed ID: 3521559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Senegalese experience with the efficacy of ivermectin (MK 933) in the treatment of human onchocerciasis (double-blind comparative study with diethylcarbamazine citrate) (DEC.C)].
    Diop Mar I; Diallo S; Diallo JS; Ndir O; Badiane S
    Bull Acad Natl Med; 1986 Jan; 170(1):149-55. PubMed ID: 3527347
    [No Abstract]   [Full Text] [Related]  

  • 7. [Management in Senegal of the 1st efficacy and tolerability studies of ivermectin (MK 933) in human onchocerciasis].
    Diallo S; Larivière M; Diop Mar I; N'Dir O; N'Diaye R; Badiane S; Porta M; Aziz M
    Bull Soc Pathol Exot Filiales; 1984; 77(2):196-205. PubMed ID: 6373039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivermectin in onchocerciasis.
    Coulaud JP; Lariviere M; Aziz MA; Gervais MC; Gaxotte P; Deluol AM; Cenac J
    Lancet; 1984 Sep; 2(8401):526-7. PubMed ID: 6147589
    [No Abstract]   [Full Text] [Related]  

  • 9. Ivermectin in onchocerciasis control in the forest zone of Cote d'Ivoire.
    Soungalo T; Soumana D; Moussa S; François R
    Acta Trop; 1997 Dec; 68(3):297-300. PubMed ID: 9492914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of drugs against Onchocerca microfiliariae in an inbred mouse model.
    Bianco AE; Nwachukwu MA; Townson S; Doenhoff MJ; Muller RL
    Trop Med Parasitol; 1986 Mar; 37(1):39-45. PubMed ID: 3486446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes.
    Bockarie MJ; Alexander ND; Hyun P; Dimber Z; Bockarie F; Ibam E; Alpers MP; Kazura JW
    Lancet; 1998 Jan; 351(9097):162-8. PubMed ID: 9449870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
    Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of human onchocerciasis with ivermectin].
    Coulaud JP; Larivière M; Gervais MC; Gaxotte P; Aziz A; Deluol AM; Cenac J
    Bull Soc Pathol Exot Filiales; 1983 Nov; 76(5):681-8. PubMed ID: 6689518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthelmintic efficacy of ivermectin given intramuscularly in horses.
    DiPietro JA; Todd KS; Lock TF; McPherron TA
    Am J Vet Res; 1982 Jan; 43(1):145-8. PubMed ID: 6896407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
    Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
    Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of ivermectin against Onchocerca cervicalis microfilarial dermatitis in horses.
    Herd RP; Donham JC
    Am J Vet Res; 1983 Jun; 44(6):1102-5. PubMed ID: 6688162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of equine onchocerciasis with ivermectin paste.
    Pollitt CC; Holdsworth PA; Kelly WR; Meacham CS; Sheahan B
    Aust Vet J; 1986 May; 63(5):152-6. PubMed ID: 3755903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemotherapy of onchocerciasis. XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in northern Ghana.
    Awadzi K; Dadzie KY; Schulz-Key H; Gilles HM; Fulford AJ; Aziz MA
    Ann Trop Med Parasitol; 1986 Aug; 80(4):433-42. PubMed ID: 3539046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
    Cupp EW; Sauerbrey M; Richards F
    Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
    Fischer PU; King CL; Jacobson JA; Weil GJ
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005163. PubMed ID: 28056015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.